Evaluation and diagnostic usefulness of saliva for detection of HIV antibodies: A cross-sectional study.

Antibodies HIV saliva serum

Journal

Journal of family medicine and primary care
ISSN: 2249-4863
Titre abrégé: J Family Med Prim Care
Pays: India
ID NLM: 101610082

Informations de publication

Date de publication:
May 2020
Historique:
received: 21 01 2020
revised: 13 03 2020
accepted: 15 03 2020
entrez: 6 8 2020
pubmed: 6 8 2020
medline: 6 8 2020
Statut: epublish

Résumé

Use of saliva as a specimen for detection of antibodies to infectious agents has generated particular interest in AIDS research community since 1980s. HIV specific antibodies of immunoglobulin isotypes IgA, IgG, and IgM are readily found in salivary secretions. In the present study, HIV specific antibodies were detected in saliva and serum samples of HIV patients by ELISA in confirmed HIV seropositive patients and efficacy of saliva was established in diagnosis of HIV. The 100 saliva and serum samples were collected from age and sex matched confirmed HIV seropositive subjects and 100 Healthy Controls without any infections. HIV antibodies were determined by enzyme-linked immunosorbent assay (ELISA) using Genscreen HIV 1/2 Kit. The results were found to be 99% sensitive and 100% specific for saliva samples, while it was 100% sensitive and specific for serum samples. Saliva can be used as alternative to blood for detection of HIV antibodies as saliva collection is painless, non-invasive, inexpensive, simple, and rapid. Salivary antibody testing may provide better access to epidemic outbreaks, children, large populations, hard-to-reach risk groups and may thus play a major role in the surveillance and control of highly infectious diseases.

Sections du résumé

BACKGROUND BACKGROUND
Use of saliva as a specimen for detection of antibodies to infectious agents has generated particular interest in AIDS research community since 1980s. HIV specific antibodies of immunoglobulin isotypes IgA, IgG, and IgM are readily found in salivary secretions.
AIM AND OBJECTIVES OBJECTIVE
In the present study, HIV specific antibodies were detected in saliva and serum samples of HIV patients by ELISA in confirmed HIV seropositive patients and efficacy of saliva was established in diagnosis of HIV.
METHODS METHODS
The 100 saliva and serum samples were collected from age and sex matched confirmed HIV seropositive subjects and 100 Healthy Controls without any infections. HIV antibodies were determined by enzyme-linked immunosorbent assay (ELISA) using Genscreen HIV 1/2 Kit.
RESULTS RESULTS
The results were found to be 99% sensitive and 100% specific for saliva samples, while it was 100% sensitive and specific for serum samples.
CONCLUSION CONCLUSIONS
Saliva can be used as alternative to blood for detection of HIV antibodies as saliva collection is painless, non-invasive, inexpensive, simple, and rapid. Salivary antibody testing may provide better access to epidemic outbreaks, children, large populations, hard-to-reach risk groups and may thus play a major role in the surveillance and control of highly infectious diseases.

Identifiants

pubmed: 32754516
doi: 10.4103/jfmpc.jfmpc_138_20
pii: JFMPC-9-2437
pmc: PMC7380795
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2437-2441

Informations de copyright

Copyright: © 2020 Journal of Family Medicine and Primary Care.

Déclaration de conflit d'intérêts

There are no conflicts of interest.

Références

PLoS One. 2007 Apr 11;2(4):e367
pubmed: 17426815
AIDS. 1991 Nov;5(11):1391-2
pubmed: 1768391
AIDS Patient Care STDS. 2007 Sep;21(9):621-37
pubmed: 17919089
AIDS. 1992 Sep;6(9):953-7
pubmed: 1388907
Open Virol J. 2010;4:88-93
pubmed: 21673840
Lancet. 1987 Jul 11;2(8550):72-5
pubmed: 2885575
Antivir Ther. 2009;14(5):619-29
pubmed: 19704164
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000 Apr;89(4):432-40
pubmed: 10760726
Clin Diagn Lab Immunol. 1998 Mar;5(2):171-5
pubmed: 9521138
J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Sep 1;10(1):41-7
pubmed: 7648283
N Engl J Med. 2013 Jun 6;368(23):2210-8
pubmed: 23738546
J Virol Methods. 2009 Oct;161(1):177-80
pubmed: 19523984
Oral Dis. 2006 May;12(3):219-28
pubmed: 16700731
Clin Diagn Lab Immunol. 1995 Jul;2(4):395-9
pubmed: 7583912
Viral Immunol. 1991 Spring;4(1):17-22
pubmed: 2064721
J Virol. 2001 May;75(10):4936-40
pubmed: 11312368
J Clin Microbiol. 1992 Nov;30(11):2780-3
pubmed: 1452645

Auteurs

Puneeta Vohra (P)

Department of Oral Medicine and Radiology, Faculty of Dental Sciences, S.G.T. University, Gurugram, Haryana, India.

Vikram Belkhode (V)

Department of Prosthodontics, Sharad Pawar Dental College and Hospital, Sawangi, Wardha, Maharashtra, India.

Sharayu Nimonkar (S)

Department of Prosthodontics, Sharad Pawar Dental College and Hospital, Sawangi, Wardha, Maharashtra, India.

Suraj Potdar (S)

Department of Orthodontics and Dentofacial Orthopedics, Vasantdada Patil Dental College and Hospital, Sangli - Tasgaon Rd, Kavalapur, Maharashtra, India.

Rishabh Bhanot (R)

Consultant Oral and Maxillofacial Surgeon, Jyoti Kendra General Hospital, Ludhiana, Punjab, India.
Department of Microbiology, Government Medical College and Associated Hospital Rajouri, Jammu and Kashmir, India.

Rahul Vinay Chandra Tiwari (RVC)

Consultant Oral and Maxillofacial Surgeon, CLOVE Dental and OMNI Hospitals, Visakhapatnam, Andhra Pradesh, India.

Classifications MeSH